Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 1
2013 3
2014 6
2015 4
2016 12
2017 8
2018 8
2019 11
2020 20
2021 26
2022 15
2023 15
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis.
Menz BD, Kuderer NM, Bacchi S, Modi ND, Chin-Yee B, Hu T, Rickard C, Haseloff M, Vitry A, McKinnon RA, Kichenadasse G, Rowland A, Sorich MJ, Hopkins AM. Menz BD, et al. Among authors: kichenadasse g. BMJ. 2024 Mar 20;384:e078538. doi: 10.1136/bmj-2023-078538. BMJ. 2024. PMID: 38508682 Free PMC article.
Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection.
Tiruye T, O'Callaghan M, FitzGerald LM, Moretti K, Jay A, Higgs B, Kichenadasse G, Caughey G, Roder D, Beckmann K. Tiruye T, et al. Among authors: kichenadasse g. Clin Genitourin Cancer. 2024 Apr;22(2):599-609.e2. doi: 10.1016/j.clgc.2024.01.018. Epub 2024 Feb 1. Clin Genitourin Cancer. 2024. PMID: 38369388 Free article.
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
Conduit C, Davis ID, Goh JC, Kichenadasse G, Gurney H, Harris CA, Pook D, Krieger L, Parnis F, Underhill C, Adams D, Roncolato F, Joshua A, Ferguson T, Prithviraj P, Morris M, Harrison M, Begbie S, Hovey E, George M, Liow EC, Link EK, McJannett M, Gedye C; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP); UNISoN Investigators. Conduit C, et al. Among authors: kichenadasse g. BJU Int. 2024 Feb;133 Suppl 3:57-67. doi: 10.1111/bju.16190. Epub 2023 Nov 20. BJU Int. 2024. PMID: 37986556 Clinical Trial.
Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges.
Wardill HR, Wooley LT, Bellas OM, Cao K, Cross CB, van Dyk M, Kichenadasse G, Bowen JM, Zannettino ACW, Shakib S, Crawford GB, Boublik J, Davis MM, Smid SD, Price TJ. Wardill HR, et al. Among authors: kichenadasse g. Br J Cancer. 2024 Jan;130(1):19-30. doi: 10.1038/s41416-023-02466-w. Epub 2023 Oct 26. Br J Cancer. 2024. PMID: 37884682 Free PMC article. Review.
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma.
Stringer BW, De Silva MI, Greenberg Z, Noreña Puerta A, Adams R, Milky B, Zabolocki M, van den Hurk M, Ebert LM, Fairly Bishop C, Conn SJ, Kichenadasse G, Michael MZ, Ormsby RJ, Poonoose S, Bardy C. Stringer BW, et al. Among authors: kichenadasse g. Sci Adv. 2023 Oct 27;9(43):eadf1332. doi: 10.1126/sciadv.adf1332. Epub 2023 Oct 25. Sci Adv. 2023. PMID: 37878712 Free PMC article.
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
Modi ND, Kichenadasse G, Hoffmann TC, Haseloff M, Logan JM, Veroniki AA, Venchiarutti RL, Smit AK, Tuffaha H, Jayasekara H, Manning-Bennet A, Morton E, McKinnon RA, Rowland A, Sorich MJ, Hopkins AM. Modi ND, et al. Among authors: kichenadasse g. BMC Med. 2023 Oct 23;21(1):400. doi: 10.1186/s12916-023-03113-0. BMC Med. 2023. PMID: 37872545 Free PMC article.
120 results